Integrated Advisors Network’s State Street SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
Other funds holding XBI
JFG
Integrated Advisors Network's XBI Position: Q2 2026 in Review
Integrated Advisors Network reduced its State Street SPDR S&P Biotech ETF (XBI) stake by 22% in Q2 2026, selling an estimated $84.2K and leaving 2,260 shares worth $358K. The position accounts for 0.02% of the portfolio, ranked #527.
Integrated Advisors Network first reported a position in XBI in Q4 2020 and has held it in 14 quarters since. The position peaked at $664K in Q1 2024. 934 funds tracked by Wall St. Rank hold XBI as of Q2 2026.
- Integrated Advisors Network held 2,260 shares of State Street SPDR S&P Biotech ETF worth $358K as of Q2 2026.
- Integrated Advisors Network sold 623 State Street SPDR S&P Biotech ETF shares in Q2 2026, an estimated $84.2K.
- State Street SPDR S&P Biotech ETF made up 0.02% of Integrated Advisors Network's portfolio in Q2 2026, its #527 holding.
- Integrated Advisors Network first reported a position in State Street SPDR S&P Biotech ETF in Q4 2020 and has held it in 14 quarters since.
- Integrated Advisors Network's State Street SPDR S&P Biotech ETF position peaked at $664K in Q1 2024.
- 934 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2026.
Based on Integrated Advisors Network's 13F filing for Q2 2026, filed 11 Aug 2026.